Miles White News
Most Popular Miles White Story
Abbott CEO White still interested in fresh acquisitions
Abbott Labs spent more than $10 billion on new acquisitions last year, but the company's CEO says his appetite for buyouts has yet to be completely sated. "We're obviously focused on the integration... Read more...
Latest Headlines
- February 4, 2010
- March 20, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
